DIAGNOSTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN REAL CLINICAL PRACTICE: HYPODIAGNISTICS OR HYPERDIAGNOSTICS
Abstract
According to the data of the world statistics there is observed the continuous growth of chronic obstructive pulmonary disease (COPD). According to the last data of the World health organization (WHO), for today there is near 250 mln persons with chronic obstructive pulmonary disease (COPD), and this disease becomes as cause of death of near 3 mln persons annually.
Aim: to establish the prevalence of undiagnosed chronic pulmonary disease (COPD) among persons, who consider themselves as healthy ones and regularly undergo medical check-ups; to estimate the frequency of chronic obstructive pulmonary disease (COPD) according to the data of medical documentation.
Methods and materials: 525 persons, older than 35, who did not have in an anamnesis any chronic diseases of respiratory tract, were interrogated. At the following stage, persons, who had taken 18 points or more underwent a spirography with bronchodilatation test, using 400 mcg of salbutamol and were interrogated by the modified questionnaire of short breath by the medical research council (MRC) and test of the chronic obstructive pulmonary disease estimation (COPD) (TEC). There were examined 136 patients, mean age (51,5±0,8), men were 81(59,5 %) mean age (52,2±1,1) and women – 55(40,4 %) mean age (50,7±0,9).
There were analyzed 56 medical stories of patients, treated at therapeutic departments of the city clinic because of internal organs diseases with the concomitant diagnosis of chronic obstructive pulmonary disease (COPD).
Among persons with first revealed chronic obstructive pulmonary disease у 21 (26,6 %) was reveled І severity degree according to GOLD, in 26 persons (32,9 %) – GOLD ІІ, in 28 (35,4 %) – GOLD ІІІ, in 4 (5,1 %) – GOLD ІV severity degree, so 32 patients did not receive basic treatment at all.
At the same time among patients with COPD diagnosis in medical documentation only in 38,4 % this diagnosis was spirographically verified, the hyperdiagnostics of disease on the base of complaints and age characteristic took place in other cases.
Downloads
References
Global Initiative for Chronic Obstructive Pulmonary Disease (2010). Global Strategy for the Diagnosis, Management, and Prevention of COPD. Available at: http://goldcopd.org/
Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D. et. al. (2010). Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory Research, 11 (1), 122. doi: 10.1186/1465-9921-11-122
Feshchenko, Yu., Yashina, L., Dzublik, A., Gavrisuk, V. (2011). Actual problems of treatment of patients with chronic obstructive pulmonary disease. Health Of Ukraine. Kyiv, 10–11.
Bourbeau, J. (2010). Preventing Hospitalization for COPD Exacerbations. Seminars in Respiratory and Critical Care Medicine, 31 (3), 313–320. doi: 10.1055/s-0030-1254071
Pro zatverdzhennya ta vprovadzhennya mediko-tekhnologichnyh dokumentiv zi standartyzatsii medychnoi dopomogy pry khronichnomu obstruktyvnomu zakhvoruvanni legen (2013). MOZ Ukrainy, No. 555. Available at: http://www.moz.gov.ua/ua/portal/dn_20130627_0555.html
McDonough, J. E., Yuan, R., Suzuki, M., Seyednejad, N., Elliott, W. M., Sanchez, P. G. et. al. (2011). Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 365 (17), 1567–1575. doi: 10.1056/nejmoa1106955
Feshchenko, Yu. (2010). Actual issues of chronic obstructive pulmonary disease. Ukrainian Pulmonology Journal, 1, 6–10.
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Mullerova, H., Tal-Singer, R. et. al. (2010). Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 363 (12), 1128–1138. doi: 10.1056/nejmoa0909883
Kim, S. J. (2011). Chronic obstructive pulmonary disease (COPD) is associated with systemic inflammation. International Journal of Tuberculosis and Lung Disease, 15 (9), 1265–1270.
Agusti, A. G. N. (2005). Systemic Effects of Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society, 2 (4), 367–370. doi: 10.1513/pats.200504-026sr
Pro zatverdzhennya ta vprovadzhennya mediko-tekhnologichnyh dokumentiv zi standartyzatsii medychnoi dopomogypry pry pynenni vzhyvannya tyutyunovykh vyrobiv (2012). MOZ Ukrainy, No. 601. Available at: http://www.moz.gov.ua/ua/portal/dn_20120803_601.html
Rashton, L. (2007). Occupational causes of obstructive pulmonary disease. Reviews on Environmental Health, 22 (3), 195–212.
Barnes, P. J. (2010). Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs. PLoS Medicine, 7 (3), 100–102. doi: 10.1371/journal.pmed.1000220
Mostovoy, Yu., Rasputina, L., Cherepiy, N. (2015). Diagnosis of symptoms of chronic obstructive pulmonary disease according to the survey. Medicine today and tomorrow, 2 (67), 59–65.
Linnyk, M. I., Nedospasova, O. V., Antonenko, L. F. (2010). Comparative data on the prevalence of respiratory diseases and medical care of patients with diseases of pulmonary profile in Ukraine in 2008–2010. Kyiv, 34.
Rebrova, O. (2006). Statistical analysis of medical data. Application of software package STATISTICA. Moscow: Mediasfera, 312.
Cherepiy, N. (2015). Diagnosis of risk factors for chronic obstructive pulmonary disease according to the survey of persons organized team. Visnyk VNMU, 19 (2), 448–452.
Sidney, S., Sorel, M., Quesenberry, C. P., DeLuise, C., Lanes, S., Eisner, M. D. (2005). COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program. Chest, 128 (4), 2068–2075. doi: 10.1378/chest.128.4.2068
Hurd, S. S., Lenfant, C. (2005). COPD: good lung health is the key. The Lancet, 366 (9500), 1832–1834. doi: 10.1016/s0140-6736(05)67634-9
National Heart Lung and Blood Institute (2009). Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases.Bethesda, National Heart, Lung, and Blood Institute. Available at: https://www.nhlbi.nih.gov/
Copyright (c) 2017 Nataliya Cherepii, Lesia Rasputina
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.